drugset / Trial / NCT00945841

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

NCT00945841 ↗

Phase 3 Completed 126 enrolled Novartis Novartis Vaccines · collab
RandomizedSingle-groupOpen-labelPrevention

Summary

This study is an annual trial for registration of inactivated split influenza vaccine with strain composition for season 2009/2010.

Timeline

Start
2009-06
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Inactivated Split Influenza Vaccine Vaccine 1 unknown —

Indications